• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性麻醉剂的最新进展。

Update on inhalational anaesthetics.

作者信息

De Hert Stefan G, Preckel Benedikt, Schlack Wolfgang S

机构信息

Division of Cardiothoracic and Vascular Anaesthesiology, Department of Anaesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Curr Opin Anaesthesiol. 2009 Aug;22(4):491-5. doi: 10.1097/ACO.0b013e32832bca38.

DOI:10.1097/ACO.0b013e32832bca38
PMID:19369864
Abstract

PURPOSE OF REVIEW

Inhalational anaesthetic agents are a cornerstone in modern anaesthetic practice. The currently used compounds are very effective and have a good safety profile. In addition, it has been demonstrated that they possess organ-protective properties that might provide an additional tool in the treatment or prevention of the consequences of organ ischaemia-reperfusion injury or both. The present review summarizes some of the most recent findings on this subject.

RECENT FINDINGS

The mechanisms underlying the organ-protective effects of inhalational anaesthetics continue to be further unravelled. The main challenge, however, is to determine the clinical importance of these protective effects and their potential benefits for patients. Initial observations in cardiac surgery are encouraging, and the first clinical studies on other organ systems are being published. Noble gases share these organ-protective properties and may provide an additional tool for this purpose both in situations in which anaesthesia is needed (xenon) or in cases in which anaesthesia is not necessary (helium).

SUMMARY

In the experimental setting, inhalational anaesthetics have protective effects against ischaemia-reperfusion injury. Initial perioperative data suggest that these effects may also result into clinically relevant improved organ function. However, further research will be needed to reveal whether these organ-protective properties will ultimately translate into an improved short-term and long-term postoperative outcome.

摘要

综述目的

吸入麻醉剂是现代麻醉实践的基石。目前使用的化合物非常有效且安全性良好。此外,已经证明它们具有器官保护特性,这可能为治疗或预防器官缺血再灌注损伤的后果或两者提供额外的手段。本综述总结了关于该主题的一些最新发现。

最新发现

吸入麻醉剂器官保护作用的潜在机制仍在进一步探索中。然而,主要挑战在于确定这些保护作用的临床重要性及其对患者的潜在益处。心脏手术中的初步观察结果令人鼓舞,关于其他器官系统的首批临床研究也正在发表。惰性气体也具有这些器官保护特性,并且在需要麻醉的情况(氙气)或不需要麻醉的情况(氦气)下都可能为此提供额外的手段。

总结

在实验环境中,吸入麻醉剂对缺血再灌注损伤具有保护作用。围手术期的初步数据表明,这些作用也可能导致临床上相关器官功能的改善。然而,需要进一步研究以揭示这些器官保护特性最终是否会转化为术后短期和长期结果的改善。

相似文献

1
Update on inhalational anaesthetics.吸入性麻醉剂的最新进展。
Curr Opin Anaesthesiol. 2009 Aug;22(4):491-5. doi: 10.1097/ACO.0b013e32832bca38.
2
Inhalational anaesthetics and cardioprotection.吸入性麻醉剂与心脏保护
Handb Exp Pharmacol. 2008(182):187-207. doi: 10.1007/978-3-540-74806-9_9.
3
[Xenon - noble gas with organprotective properties].[氙气——具有器官保护特性的惰性气体]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Aug;39(8):456-62. doi: 10.1055/s-2004-825736.
4
[Myocardial protection by volatile anesthetics].[挥发性麻醉剂对心肌的保护作用]
Anaesthesiol Reanim. 2002;27(5):116-23.
5
Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?非心脏器官的预处理及对缺血再灌注的保护:挥发性麻醉剂能发挥作用吗?
Eur J Anaesthesiol. 2007 Sep;24(9):733-45. doi: 10.1017/S0265021507000531. Epub 2007 Jun 7.
6
Inert gases as the future inhalational anaesthetics?惰性气体作为未来的吸入性麻醉剂?
Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):365-79. doi: 10.1016/j.bpa.2005.01.002.
7
[Xenon anaesthesia--clinical characteristics, benefits and disadvantages and fields of application].[氙气麻醉——临床特征、优缺点及应用领域]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2012 Jun;47(6):374-80. doi: 10.1055/s-0032-1316478. Epub 2012 Jun 28.
8
Inhalation anaesthesia: from diethyl ether to xenon.吸入麻醉:从乙醚到氙气。
Handb Exp Pharmacol. 2008(182):121-42. doi: 10.1007/978-3-540-74806-9_6.
9
Brain protection by anesthetic agents.麻醉药物的脑保护作用。
Curr Opin Anaesthesiol. 2006 Oct;19(5):481-6. doi: 10.1097/01.aco.0000245271.84539.4c.
10
Volatile anesthetics and cardiac function.挥发性麻醉剂与心脏功能。
Semin Cardiothorac Vasc Anesth. 2006 Mar;10(1):33-42. doi: 10.1177/108925320601000107.

引用本文的文献

1
Inhaled Anesthetics: Environmental Role, Occupational Risk, and Clinical Use.吸入麻醉剂:环境作用、职业风险及临床应用
J Clin Med. 2021 Mar 22;10(6):1306. doi: 10.3390/jcm10061306.
2
Cardiac Preconditioning Effect of Ketamine-Dexmedetomidine versus Fentanyl-Propofol during Arrested Heart Revascularization.氯胺酮-右美托咪定与芬太尼-丙泊酚在心脏停搏血管重建术中的心脏预处理效果
Anesth Essays Res. 2020 Apr-Jun;14(2):312-320. doi: 10.4103/aer.AER_55_20. Epub 2020 Oct 12.
3
New advances in perioperative cardioprotection.围手术期心脏保护的新进展
F1000Res. 2019 Apr 24;8. doi: 10.12688/f1000research.17184.1. eCollection 2019.
4
Sevoflurane.七氟烷
F1000Res. 2015 Aug 25;4(F1000 Faculty Rev):626. doi: 10.12688/f1000research.6288.1. eCollection 2015.
5
Update on complications in pediatric anesthesia.小儿麻醉并发症的最新进展。
Pediatr Rep. 2013 Feb 18;5(1):e2. doi: 10.4081/pr.2013.e2. Print 2013 Feb 5.
6
Xenon: a solution for anesthesia in liver disease?氙气:肝病麻醉的一种解决方案?
Hepat Mon. 2012 Nov;12(11):e8437. doi: 10.5812/hepatmon.8437. Epub 2012 Nov 20.
7
Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?七氟醚挥发性麻醉药药理学预处理在肝手术中提供保护作用吗?
HPB (Oxford). 2012 Dec;14(12):854-62. doi: 10.1111/j.1477-2574.2012.00570.x. Epub 2012 Sep 25.
8
The future of anaesthetic pharmacology.麻醉药理学的未来。
Indian J Anaesth. 2009 Oct;53(5):533-6.